New York, Jan. 15, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Cannabis Testing Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Product ; Service ; End User, and Country” – https://www.reportlinker.com/p06004156/?utm_source=GNW
However, the cannabis used as a street drug and trouble with CBD oil are the factors negatively impacting the growth of the market in the coming years.
With the legalization of Cannabis in Europe, producers are looking for a quick and accurate means of determining their products’ quality and potency.The growing use of Cannabis results in increasing demand for Cannabis testing, which, in turn promotes the research activities in the region.
The European Parliament is calling for an EU-wide policy for medical Cannabis and properly funded scientific research. To achieve this, in February 2019, members of the European Parliament (MEPs) adopted a resolution on the use of Cannabis for medicinal purposes.
Various European countries have legalized the medical use of Cannabis or cannabinoids and are considering their legislation changes for legalization of Cannabis. The main purpose of the resolution is to draw a clear distinction between medical Cannabis and other Cannabis uses.
However, no EU country authorizes the smoking or home-growing of Cannabis for medical purposes.At the same time, the World Health Organization (WHO) has officially recommended that the Cannabis compound cannabidiol (CBD) should not be classified as a controlled substance.
However, at present, there are no EU-wide rules for either the medical or recreational use